Common illnesses are no longer just a checklist of symptoms. Over the past two years, the way they are managed in France has significantly changed, influenced by new regulatory measures and a reorganization of the care pathway. Understanding these developments allows for better navigation in an increasingly complex healthcare system.
Long Covid Care Pathway: A Three-Tier Structure
Long Covid remains one of the least covered topics in general articles about common illnesses. Most merely mention prolonged symptoms (fatigue, cognitive fog, shortness of breath) without detailing the concrete management.
Since May 2024, the Haute Autorité de santé (HAS) has published recommendations to structure the care pathway for adults with prolonged symptoms of Covid-19. This pathway is organized into three levels of care:
- First level: General practitioners, placed at the center of the system, ensure the initial assessment and regular follow-up of the patient.
- Second level: City or hospital specialists (pulmonologists, cardiologists, neurologists, ENT specialists) intervene when symptoms persist or worsen despite primary care management.
- Third level: Medical care and rehabilitation services accommodate complex cases requiring a multidisciplinary approach.
This national organization contrasts with the confusion that prevailed in previous years, where patients moved from one specialist to another without clear coordination. To delve deeper into these topics, health information on Just Healthy helps better understand pathologies and their mechanisms.
Lead Nurse for Patients with Long-Term Conditions: Changes from the May 2026 Regulation
Long-term conditions (LTC) affect a significant portion of the French population. Diabetes, cancers, cardiovascular diseases, psychiatric disorders: these chronic illnesses require regular follow-up, often fragmented among several healthcare professionals.
Since May 6, 2026, a new regulatory measure allows patients with LTC to designate a lead nurse. Their role is not limited to technical care. They coordinate the care pathway, ensure the link between the primary care physician and specialists, and assist the patient in the daily management of their illness.
This change addresses a simple observation: coordination among healthcare professionals remained the weak link in the management of chronic diseases. A diabetic patient, for example, consults their general practitioner, endocrinologist, ophthalmologist, and podiatrist. Without coordination, information flows poorly, tests are sometimes redundant, and the patient ends up managing the logistics of their care alone.
Field feedback still varies regarding the practical application of this measure. Some regions lack nurses trained for this coordination role, and the remuneration framework is still being clarified.
Medical Deductibles and Out-of-Pocket Costs: A Factor in Renouncing Care
Understanding common illnesses goes beyond biology. Access to care plays a direct role in how a pathology evolves. A prescribed treatment that is not purchased due to lack of funds leads to a worsening condition.
A proposal to double the cap on medical deductibles has sparked strong reactions in the associative sector and among healthcare professionals. These deductibles, applied to medication boxes, paramedical acts, and medical transport, primarily affect patients with chronic illnesses, those who consume the most care.
For patients with LTC, the paradox is striking: their condition grants them rights to enhanced care, but the deductibles chip away at these rights with small amounts that accumulate. Patient associations denounce a violation of the principle of solidarity and access to care.
Autumn 2026 is expected to be particularly costly for chronic patients, with the anticipated implementation of these new rules. The issue of renouncing care for financial reasons is not new, but it takes on an additional dimension when it affects conditions whose worsening incurs significantly higher costs for the healthcare system.
Vector-Borne Diseases in Metropolitan France: An Expanding Health Risk
Diseases transmitted by mosquitoes or ticks are no longer confined to tropical areas. In metropolitan France, the geographical expansion of the tiger mosquito and ticks is changing the map of health risks.
Dengue, chikungunya, and the Zika virus are subject to enhanced surveillance every summer. Ticks, on the other hand, transmit Lyme disease and other less well-known pathogens to the general public. The European Centre for Disease Prevention and Control (ECDC) closely monitors these threats, with weekly reports on communicable diseases in Europe.
Individual prevention remains the primary lever: wearing covering clothing, using repellents, and inspecting the body after a walk in the woods. In contrast, collective prevention (vector control, urban planning, entomological surveillance) falls under public policies whose resources vary by department.
What is striking in this area is the gap between the reality of the risk and public perception. Vector-borne diseases are still associated with distant travel in the minds of most French people, while indigenous cases of dengue are reported every year in the mainland.
Understanding common illnesses also involves updating representations. The pathologies that are gaining strength are not always the ones that are most closely monitored, and care management measures evolve faster than the information circulating among the general public. Keeping track of these changes is key to gaining autonomy regarding one’s own health.